Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07538063 · ClinicalTrials.gov registry record · NA
Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity
A NA study, sponsored by Hunter College of City University of New York.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07538063: Active NA study, sponsored by Hunter College of City University of New York.
NCT07538063 is a NA study that is active but no longer recruiting, run by Hunter College of City University of New York. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07538063, a NA study, is active but no longer recruiting, sponsored by Hunter College of City University of New York.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study compared two educational methods. Participants were assigned to participate in a 360-degree experience or a slideshow presentation. The 360-degree video group included a brain and MS program. The comparison group was given a slideshow presentation with the same information. Participants viewed the 360-degree program or the slideshow presentation only once. The online-based materials consisted of a demographic form (age, gender, race and ethnicity, and name of school), knowledge questionnaires, and an experiential learning scale. Pre-intervention, participants were asked about demographic information, whether they had previous experience with MS, the science classes they completed in high school and college, and their knowledge of the human brain and MS pathophysiology. At both pre- and post-intervention, participants completed the Multiple Sclerosis Magnetic Resonance Imaging Knowledge Questionnaire (MSMRIKQ) and the Multiple Sclerosis Knowledge Questionnaire (MSKQ). At post-intervention, participants completed a lesson experiential questionnaire about their experience viewing either the 360-degree video or the slideshow presentation. Permission to use the three instruments was obtained from their respective copyright holders.
Primary Outcome
The learning effectiveness was evaluated by two instruments. Outcomes assessed using the MS Knowledge Questionnaire(MSKQ), the MS Magnetic Resonance Imaging Knowledge Questionnaire(MSMRIKQ). The MSMRIKQ is a 20-item questionnaire16 that assesses knowledge about MS and MRI. Face validity was established on all MSMRIKQ items.24 The Kuder-Richardson 20 (KR-20) reliability estimate for the entire scale was 0.58. The split-half reliability with Spearman-Brown correction for the total scale was 0.60.
Interventions
- OTHER The immersive 360-degree educational video
- OTHER The slideshow (PowerPoint) educational presentation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT07538063 still lists
NCT07538063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which The immersive 360-degree educational video is the first listed.
NCT07538063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07538063 about?
NCT07538063 is a clinical study titled "Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity". This study compared two educational methods. Participants were assigned to participate in a 360-degree experience or a slideshow presentation. The 360-degree video group included a brain and MS program. The comparison group was given a slideshow presentation with the same information. Participants v...
What is the current status of trial NCT07538063?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-07-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07538063?
The interventions under investigation include: The immersive 360-degree educational video (OTHER), The slideshow (PowerPoint) educational presentation (OTHER).
Who is sponsoring clinical trial NCT07538063?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07538063's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI